We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

27 hedge funds and large institutions have $1.44M invested in Microbot Medical in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

0.03% more ownership

Funds ownership: 0.34% → 0.37% (+0.03%)

4% less funds holding

Funds holding: 28 → 27 (-1)

29% less capital invested

Capital invested by funds: $2.01M → $1.44M (-$577K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$68.7K
2
TSS
Two Sigma Securities
New York
+$32.4K
3
AG
Advisor Group
Arizona
+$23.4K
4
UBS Group
UBS Group
Switzerland
+$14.3K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.68K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.84K
3
Morgan Stanley
Morgan Stanley
New York
-$1.3K
4
SM
Sabby Management
Florida
-$540
5
BlackRock
BlackRock
New York
-$216
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$843K -$540 -40 -0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$308K +$7.68K +569 +2%
Citadel Advisors
3
Citadel Advisors
Florida
$99K +$68.7K +5,086 +109%
BlackRock
4
BlackRock
New York
$36K -$216 -16 -0.4%
TSS
5
Two Sigma Securities
New York
$33K +$32.4K +2,398 +291%
ZCA
6
Zeke Capital Advisors
Pennsylvania
$27K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$24K -$1.84K -136 -5%
AG
8
Advisor Group
Arizona
$18K +$23.4K +1,733 +173,300%
UBS Group
9
UBS Group
Switzerland
$17K +$14.3K +1,055 +150%
Northern Trust
10
Northern Trust
Illinois
$10K – – –
GC
11
Guggenheim Capital
Illinois
$8K +$68 +5 +0.6%
WS
12
Wedbush Securities
California
$7K – – –
IWM
13
IHT Wealth Management
Illinois
$3K – – –
Wells Fargo
14
Wells Fargo
California
$2K – – –
FDCDDQ
15
Federation des caisses Desjardins du Quebec
Quebec, Canada
$37 – – –
RE
16
RBC Europe
United Kingdom
$2 – – –
Deutsche Bank
17
Deutsche Bank
Germany
– -$2K -171 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$1.3K -96 -52%
LTFS
19
Ladenburg Thalmann Financial Services
Florida
– -$81 -6 -86%
Citigroup
20
Citigroup
New York
– +$14 +1 New
PFO
21
Pathstone Family Office
New Jersey
– +$270 +20 +400%

MBOT Hedge Fund Activity: Q1 2018 in Review

27 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2018, worth a combined $1.44M — down 29% from $2.01M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of MBOT and 1 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 7 added.

The largest buyer was Citadel Advisors, adding an estimated $68.7K. The largest seller was Deutsche Bank, exiting entirely with an estimated $2K sold.

  • 27 institutional investors held Microbot Medical (MBOT) as of Q1 2018, down from 28 in Q4 2017.
  • Funds reported $1.44M of Microbot Medical stock for Q1 2018, down 29% quarter-over-quarter.
  • 1 fund opened new Microbot Medical positions in Q1 2018 and 2 closed out, a net change of -1 holder.
  • The largest Microbot Medical buyer in Q1 2018 was Citadel Advisors, an estimated $68.7K added.
  • The largest Microbot Medical seller in Q1 2018 was Deutsche Bank, an estimated $2K sold.

Based on aggregated 13F filings for Q1 2018.